Aug 28

Health agencies’ credibility at risk after week of blunders

First, the head of the Food and Drug Administration had to walk back exaggerated statements about the benefits of a new plasma therapy for coronavirus. Then the Centers for Disease Control and Prevention triggered a backlash from the medical community…

The Latest